Primary biliary cirrhosis in India

被引:2
作者
Shiv Kumar Sarin [1 ]
Rajnish Monga [1 ]
Bimaljeet Singh Sandhu [1 ]
Barjesh Chander Sharma [1 ]
Puja Sakhuja [2 ]
Veena Malhotra [2 ]
机构
[1] Department of Gastroenterology
[2] Department of Pathology G B Pant Hospital
关键词
D O I
暂无
中图分类号
R575.2 [肝硬变];
学科分类号
100201 [内科学];
摘要
<正>BACKGROUND: Primary biliary cirrhosis (PBC) is a rare cause of chronic liver disease in India. We analyzed the clinical, biochemical, serological and histological features of patients with PBC for over a 10-year period. METHODS: PBC was diagnosed by the presence of raised level of serum alkaline phosphatase (ALP), anti-mitochondrial antibody (AMA) positivity (1:40 dilution), and/or diagnostic liver histology. RESULTS:Fifteen female patients with mean age of 46.5±11 years were studied. Pruritis (80%) followed by jaundice (67%), skin changes (pigmentation, coarsening, xanthelesma and vitiligo) (67%) and fatigue (60%) were common symptoms. The mean duration of the symptoms was 3.5± 5.4 years (3 months to 20 years). Dryness of eyes was observed in only 2 patients. Hepatomegaly was noted in 87% of the patients and ascites at presentation in 40%. Mean levels of bilirubin and albumin at the time of diagnosis were 3.4±3.3 mg/dl and 3.5±0.8 g/dl, respectively. The level of serum ALP ranged from 54 to 2400 IU/L, with a median being 552 IU/L (2×ULN). In all the 15 patients with AMA positive, 8(53%) were also positive for either anti-nuclear or anti-smooth muscle antibodies. Two patients presented with persistently elevated SAP after an acute hepatitic illness. Liver biopsy was available in 13 patients, diagnostic of PBC Ⅱ & Ⅲ(8) and with evidence of cirrhosis (5). Associated autoimmune disorders were observed in 5 patients (33%). The mean time for follow-up was 26±21 months (1 to 87 months). In 4 deaths, 3 were due to liver related causes. CONCLUSION: PBC is a rare cause of chronic liver disease in India. PBC in India, unlike in the West, presents late, often with features of cirrhosis and decompensation.
引用
收藏
页码:105 / 109
页数:5
相关论文
共 6 条
[1]
Survival and symptom progression in a geographically based cohort of patients with primary biliary cirrhosis: Follow-up for up to 28 years [J].
Prince, M ;
Chetwynd, A ;
Newman, W ;
Metcalf, JV ;
James, OFW .
GASTROENTEROLOGY, 2002, 123 (04) :1044-1051
[2]
Primary biliary cirrhosis with additional features of autoimmune hepatitis: Response to therapy with ursodeoxycholic acid [J].
Joshi, S ;
Cauch-Dudek, K ;
Wanless, IR ;
Lindor, KD ;
Jorgensen, R ;
Batts, K ;
Heathcote, EJ .
HEPATOLOGY, 2002, 35 (02) :409-413
[3]
Treatment of primary biliary cirrhosis [J].
Poupon, R ;
Poupon, RE .
BEST PRACTICE & RESEARCH CLINICAL GASTROENTEROLOGY, 2000, 14 (04) :615-628
[4]
The geoepidemiology of primary biliary cirrhosis [J].
Metcalf, J ;
James, O .
SEMINARS IN LIVER DISEASE, 1997, 17 (01) :13-22
[5]
FREQUENCY AND SIGNIFICANCE OF ANTIMITOCHONDRIAL ANTIBODIES IN SEVERE CHRONIC ACTIVE HEPATITIS [J].
KENNY, RP ;
CZAJA, AJ ;
LUDWIG, J ;
DICKSON, ER .
DIGESTIVE DISEASES AND SCIENCES, 1986, 31 (07) :705-711
[6]
STAGING OF CHRONIC NONSUPPURATIVE DESTRUCTIVE CHOLANGITIS (SYNDROME OF PRIMARY BILIARY-CIRRHOSIS) [J].
LUDWIG, J ;
DICKSON, ER ;
MCDONALD, GSA .
VIRCHOWS ARCHIV A-PATHOLOGICAL ANATOMY AND HISTOPATHOLOGY, 1978, 379 (02) :103-112